Elixir Associates reposted this
Recent developments indicate significant growth within the radiotherapy sector. Market analysis by Mordor Intelligence suggests an increase from USD 9.77 billion in 2023 to USD 10.18 billion in 2024, with projections reaching USD 12.51 billion by 2029, based on a steady 4.2% CAGR. Factors contributing to this growth include a rise in cancer incidence, intensified research and development efforts, and heightened cancer awareness. North America presently holds the preeminent market share, whereas Asia Pacific is forecasted to experience the most rapid growth. This expansion is largely attributed to technological advancements in radiotherapy devices, which are enhancing the accessibility and efficacy of treatments for patients. Such advancement presents numerous opportunities within the Life Sciences industry. From Clinical Operations to Medical Affairs, professionals are witnessing and contributing to transformative changes in cancer care, providing tangible benefits to patient health. #Radiotherapy #CancerCare #HealthcareInnovation
